FDA-Approved AI Diagnostic Tools: Heart Disease, Skin Cancer, Lung Disease – Rolling Out in 2,000+ Hospitals
Summary:
In November 2025, at least four FDA-cleared AI diagnostic platforms entered hospital systems worldwide—CardioVision, NeuroScan Plus, DermDetect Pro and PulmoAnalyzer—raising accuracy above 95 % in real-world settings.
The procedure, called ventriculo-coronary transcatheter outward navigation and re-entry, or VECTOR, creates a new route for blood flow that is a safe distance away from the aortic valve.
Engineers have built the smallest fully autonomous robots yet, capable of sensing, computing, and acting on their own at microscopic scales, with potential applications in medicine and manufacturing.
Through the genome-wide data of 26 ancient human remains from northern and southern East Asia, spanning 9,500 to 300 years ago, including some extracted from the Qihedong skull, they carried out a series of scientific analyses that supported a southern China origin for proto-Austronesians.
The findings trace the long history of HHV-6 integration into human chromosomes and suggest that HHV-6A lost this ability early on... trace the viruses' evolution can now be traced over more than 2,500 years across Europe, using genomes from the 8th-6th century BCE until today.
Scientists have identified two new biological subtypes of multiple sclerosis using AI, blood biomarkers, and MRI scans. The discovery could lead to more accurate diagnoses and personalized treatments based on how the disease damages the nervous system.
Discover more from Changing Knowledge
Subscribe now to keep reading and get access to the full archive.
Leave a Reply